Advicenne announces the results of its capital increase with preferential subscription rights finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
02.10.2023 - Regulatory News: This press release must not be distributed directly or indirectly in the United States, Canada, Australia, or Japan. Advicenne (Euronext Growth - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and .
Advicenne Launches a Capital Increase With Preferential Subscription Rights ( PSR ) to Accelerate Growth in Europe and Optimize Clinical Development of ADV7103 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Changes in governance with the appointment of a new Chairman of the Board of Directors and a new Director Regrouping of all French Advicenne's teams in the new Paris headquarters to optimize